drugset / Trial / NCT02866253

Dehydroepiandrosterone (DHEA)Supplementation Pre-IVF(In Vitro Fertilization) Cycles

NCT02866253 ↗

Phase 4 Completed 78 enrolled ShangHai Ji Ai Genetics & IVF Institute
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to compare the effect of pre-IVF cycles treatment with and without DHEA(Dehydroepiandrosterone) on the ovarian reserve markers, the number of oocytes obtained and IVF(in vitro fertilization) outcomes of DOR(diminished ovarian reserve) patients and the expression of BMP-15(bone morphogenetic protein 15),GDF-9(growth differentiation factor 9) and IGF-I(insulin-like growth factors-1) in follicular fluid.

Timeline

Start
2014-12
Primary completion
2015-12
Completion
2016-02

Drugs

EvaluationDrugModalityDoseRoute
Subject DHEA Unknown 25 mg —

Indications